Member Info for BasilAlderman

In all the excitement people on here seem to be forgetting the unexpected find of a 2.2% hydrogen concentration. This increases the commercial potential for HE1 and our value. We are all aware of how Government's and big business are chasing clean energy solutions. Hydrogen is part of this mix. People on here should not overlook this. It's a big commercial opportunity for HE1, in addition to the helium.

Yes, I totally agree that HE1 will be sold to one of the majors and probably for over 30p a share. i.e. £1 Billion. A big global player won't want to miss out on this helium and hydrogen find. Lorna Blaisse has already informed the market of HE1's Itumbula's uniqueness due to its pure helium, nitrogen and hydrogen mix. This is massive news in our industry. That is why she is calling it "a game-changer".

Yes, I particularly liked the Lorna Blaisse quote: "This could potentially make us one of the largest primary helium sources globally". The rest of the quotes from the interview are pretty compelling also.

https://www.proactiveinvestors.co.uk/companies/news/1040405/helium-one-global-unveils-game-changing-helium-discovery-in-tanzania-icymi-1040405.html

https://finance.yahoo.com/news/helium-one-global-achieves-milestone-173744228.html

https://ukinvestormagazine.co.uk/helium-one-global-shares-surge-on-encouraging-well-tests/

https://www.fool.co.uk/2024/02/07/could-i-get-rich-from-the-helium-one-share-price-up-1000-in-a-month/

All eyes are on the next RNS. Any sniff of a JV / MOU and the share prices will rocket.

Yes, 6p should come very soon before we head to 12-15p a share judging by the share price trend of other FDA approval candidates. A sustained rise is the norm as FDA consent brings credibility, which major pharma co's require before entering in to licencing agreements. A reminder that Reata soared 178% on FDA approval before then being acquired for $7.8 Billion by Biogen last September. i.e. FDA approval brings pharma attention and deals. Amarin Corp had a sustained rise of over 300% on FDA approval, Zosano Pharma soared over 100% and Madrigal Pharmaceutical's share price went up over 400%, plus Kala shares soared 266% on FDA approval. This could be replicated with the HEMO share price in the coming days and weeks.

Yes, Lorna Blaisse in this interview highlights the magnitude of the Itumbula West-1 well succinctly as follows: "This could potentially make us one of the largest primary helium sources globally".

The full paragraph is: ".Absolutely, it's a game-changer. We're looking at helium concentrations up to 4.7%, which positions us as a world-class helium source. Considering commercial viability in other projects starts at just 0.5%, and ours is pure helium without hydrocarbons, it's a monumental achievement. This could potentially make us one of the largest primary helium sources globally".

A Term Sheet or MOU announcement for an earn-in and joint venture agreement with a major helium business such as Exxon, APD, Linde, Air Liquide etc could happen very soon. A sniff of this and the share price will sail past 10p. Remember GGP went from 3p to over 30p when its JV deal with Newcrest was announced.

Andy and Aber, an EGM is being called at VAL. Let's hope our CEO and Chair take note. My 128,000 shares in SAR will in the future now be voting for a new Chair and for TM to be moved to CSO.

Sandyman, HaHa! re Mary Poppins. You've clearly never experienced the "Supercalifragilisticexpialidocious" mega multi-bags that I and many other have. They do happen and are very likely to happen right here at HE1.

Are you not aware of BOTB which multibagged x 71 at 7,130% ? or GGP which multibagged x 63 at 6,300% ? or EUA which multibagged x 36 at 3,650% ? or VCP which multibagged x 63 at 6,312% or ESG which multibagged x 41 at 4,190%?

Sandyman these type of mega multi-bags happen regularly. Last year we also saw POS multibag x 15 from 2p to over 30P. Prior to that PYC accomplished a x 34 multibag in 4 trading days rising from 1p to 34p. 3 months ago TPST went up over x 39. Plus who can forget Axsome doing x 54 in 12 months? Then of course there's NCYT achieving a x 100. SNG going from 7p to 246p x 35. SOU going up from 2p to 70p x 35 and we also saw the mega rise at RKH Rockhopper.

You see, Sandyman, Supercalifragilisticexpialidocious gains really do happen. HE1 is most likely going to be next with the helium and hydrogenflows they have reported at Itumbula West-1. A 4.7% helium flow is not to be sniffed at. That is 9,000 times above background levels. The 2.2% hydrogen flow is over 37,000 times above background levels. This is massive. In fact it is "Supercalifragilisticexpialidocious"!

30p a share would be a reasonable (early) takeover prediction SM69. Linde (71 Billion mcap), Exxon (406 Billion mcap), Apd (48 Billion mcap), Air Liquide (89 Billion mcap) etc are all multi billion businesses and could easily takeover HE1 for £1 Billion+ / 30p a share approx or they could pen a mega JV/MOU with our company. A big deal could very well be in the pipeline.

No Cobaltblue, I still hold 128,000 shares (6.4million pre the ridiculous tinkering). I'm here for the £Billion takeover. However, as our CEO and Chairman seem to be taking much longer than I had hoped to deliver on this (this is the polite version of what I actually think about how they have handled things lately!) I have been buying in to HE1, HEMO, GST and a few others over the last few months. They've all done nicely so far. Lets hope that the SDC1801 trial is a success in Australia and that SRA737 has been farmed out to someone who is actually going to develop it this time. Then we might start to see a return to the glory days here.

Yes, Exxon is certainly one of the contenders for a JV. We all saw Greatland GGP going from .55 to over 30p with a JV. i.e. BIG gains do happen and if we get a JV / MOU / Heads of Terms RNS then we will see the HE1 share price multi-bag considerably.

The AGM was not their finest hour. They came across as very evasive and left me feeling very uncomfortable about my investment.

HE1's CEO, Lorna Blaisse, could not be clearer: We aim to achieve commerciality at the earliest opportunity". Code for this is too big for us and we need an Exxon, APD, Linde, Air Liquide etc for a JV. Watch out for a Heads of Terms / MOU / JV RNS next. No wonder people expect to see this over 10p a share soon and much much higher during 2024.

Yes the share price trend of other FDA approval candidates is an initial boost followed by a sustained rise. The FDA consent brings credibility, which the investment community requires before buying in. Amarin Corp gained over 300% on FDA approval, Zosano Pharma soared over 100% and as we know Tempest surged over x 39 (3,973%) in 2 days in October 2023. Then there's Reata soaring 178% on FDA approval, Madrigal Pharmaceutical's share price going up over 400% and Kala shares soaring 266% on FDA approval. This could be replicated with the HEMO share price in the coming days and weeks.

Yes, and quite rightly investors will now be wondering which global player is going to do a JV with HE1? Itumbula West-1 with helium flows of 4.7% is big news in our sector. It's not every days the industry gets to hear of helium almost 9,000 times above background levels and Hydrogen flowing to the surface at over 37,000 times above background levels. This is massive news in our sector.

Yes, the prospect of life-saving treatment of acute myeloid leukemia is pretty big news. What value do you attribute to something as important as this. It's huge.

Another pharma, Tempest Therapeutics, surged x 39 in 2 days a couple of months ago. This is the sector to be in for mega gains. NCYT, SAR, SNG, PYC, AVCT, TPST, Etc. We are now a P1 company with FDA approval. Let that sink in!

Yes and we've all seen inthe pharma sector the x 100 at NCYT. The x 30 at SAR. The x 34 at PYC. The x 15 at AVCT. The x 40 at SNG. We know it can and does happen.

Over the next 12 months we could see a prolonged rise in the Hemo share price, such as the x54 gain at Axsome which rose from $2 per share to $108 dollars in just 12 months. FDA approval opens the licencing door for HEMO. This is a big day.

Amarin Corp gained over 300% on FDA approval.

Amarin Corp gained over 300% on FDA approval.

When the FDA granted marketing authorisation for Renalytix's Kidney prognostic testing platform the shares jumped from 75p to 145p in 2 weeks (& went intra day to 155p. i.e. 100% gain). I think we will see a much bigger gain here. e.g. more akin to the 2020 rise from 1p to 15p that saw HEMO one of the most talked about shares at the time.